x

Join Advarra

Learn more about our company team, careers, and values. Join Advarra’s Talented team to take on engaging work in a dynamic environment.

See Jobs

 
Blog

IRB Review of Coronavirus and Other Emerging Infectious Disease Research: Issues to Consider

Advarra IRB experts discuss unique issues that research involving emerging infectious diseases like coronavirus can raise for IRB review. Read more:

Read Now
5 min. read
Read more
 
Blog

Are “Virtual Trials” Mainstream Yet?

Advarra VP of Insitutional Services James Riddle discusses using virtual trial components in traditional study designs. Read more:

Read Now
5 min. read
Read more
 
White Paper

Informed Consent: 6 Approaches to Increase Participant Comprehension

Explore six approaches for improving informed consent and supporting participants’ understanding of the studies they are asked to join.

Read Now
Read more
 
Blog

Key Biosafety Considerations for Coronavirus Research

Advarra Director of Biosafety Daniel Eisenman reviews opportunities, risks, and risk mitigation strategies for coronavirus research. Read more:

Read Now
7 min. read
Read more
 
Blog

Revised Common Rule Compliance Now in Full Effect—and What That Means

The Revised Common Rule is here after multiple delays, exceptions, and many training sessions. As of January 20, 2020, this regulation is in full effect.

Read Now
3 min. read
Read more
 
Blog

Beyond the Regulations: More Considerations for Emergency Research

Go beyond the regulatory requirements and examine three key actions research organizations must consider before conducting planned emergency research.

Read Now
7 min. read
Read more
 
Blog

Most Popular Blogs of 2019

What did the research community enjoy most in 2019? Read Advarra's most popular blogs from industry experts and IRB members here.

Read Now
2 min. read
Read more
 
Blog

Reporting to the IRB: What NOT to Report

Reportable events can be tricky: according to the regulations, not every unanticipated event should be submitted to the IRB.

Read Now
6 min. read
Read more
 
Blog

Making Sense of the New HUD Guidance

Understand how the new HUD guidance clarifies responsibilites of the IRB and institutions, while widening the access of small communities to HUDs.

Read Now
7 min. read
Read more
 
Blog

Should Social Media Be Part of Your Research Toolbox?

Social media has emerged as a valuable tool for diverse stakeholders across the research community. Learn about the risks and benefits in this article.

Read Now
5 min. read
Read more
 
Blog

Reporting to the IRB: Unanticipated Device Effects in Medical Device Studies

What do the regulations say about unanticipated device effects and IRB reporting? In this blog, Advarra addresses unique requirements for medical device studies.

Read Now
2 min. read
Read more
 
Blog

Advarra Acquires Forte:
What You Need to Know

On September 5, 2019, Advarra announced its intent to acquire Forte.

Read Now
Read more